Alexandria Real Estate Equities, Inc. (ARE)
Alexandria Real Estate: Undervalued And Poised For A Breakout
Market volatility is back, and it's taken down high quality stocks like Alexandria Real Estate. Meanwhile, lower interest rates benefit dividend stocks like Alexandria Real Estate and it's poised for strong returns and rebound in price. Alexandria Real Estate carries high-quality assets, strong operating performance, and potential for market-beating total returns.
Alexandria Real Estate: Time To Buy This Mission-Critical REIT Now
Investing in commercial real estate that tenants can't operate without is a winning business model. Alexandria Real Estate's revenue slightly missed analysts' expectations in the second quarter while FFO per share surpassed expectations. The REIT has significant liquidity on its balance sheet.
Alexandria Real Estate Equities, Inc. (ARE) Q2 2024 Earnings Call Transcript
Alexandria Real Estate Equities, Inc. (NYSE:ARE ) Q2 2024 Earnings Conference Call July 23, 2024 3:00 PM ET Company Participants Paula Schwartz - Rx Communications Group LLC, Managing Director Joel S. Marcus - Executive Chairman and Founder Hallie Kuhn - Senior Vice President of Science and Technology and Capital Markets Peter M.
Alexandria (ARE) Q2 AFFO Beats Estimates, Revenues Miss
Alexandria's (ARE) Q2 AFFO outshines estimates. Results reflect decent leasing activity and higher rental rates.
Alexandria Real Estate Equities (ARE) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alexandria Real Estate Equities (ARE) Surpasses Q2 FFO Estimates
Alexandria Real Estate Equities (ARE) came out with quarterly funds from operations (FFO) of $2.36 per share, beating the Zacks Consensus Estimate of $2.34 per share. This compares to FFO of $2.24 per share a year ago.
Is The Tide Turning For REITs?
Nasdaq had a strong start to the year, driven by big tech stocks, but recent declines have raised concerns about the index's performance. REITs have struggled in recent years but are showing signs of a potential comeback, with some stocks posting strong gains. Possibility of September rate cuts could benefit publicly traded landlords, including REITs, leading to potential share price appreciation.
Why Alexandria Real Estate Equities (ARE) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes?
Alexandria Real Estate: Undervalued Passive Income Gem With A 4.2% Yield
Alexandria Real Estate Equities is a well-managed REIT focusing on life science real estate with consistent FFO growth. The trust has a strong portfolio with high-quality tenants, high occupancy rates, and a dividend payout ratio of just over 50%. Supported by R&D spending in the pharmaceutical industry, Alexandria Real Estate Equities is expected to continue growing its dividend, making it a solid investment option.
The 3 Most Undervalued REITs to Buy in July 2024
Undervalued REITs are the way to go in the current real estate environment, which is still struggling after the Federal Reserve hiked rates 11 times from 2022 to 2023 in an effort to curb inflation. Still, it continues to be above the benchmark rate of 2%.
2 Bargain Blue Chip REITs To Buy And Never Let Go
Investing in quality companies at below average valuations can lead to strong total returns through capital appreciation and dividend reinvestment. Alexandria Real Estate and Federal Realty Trust are two stocks with moat-worthy assets and solid dividend yields. Both are trading well below their historical valuations, offering investors a great starting point from which to compound future returns.
Here's Why Alexandria (ARE) is an Apt Portfolio Pick for Now
Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.
